Array BioPharma

Array Bio Pharma

Pharmaceuticals, 3200 Walnut Street, Boulder, Colorado, 80301, United States, 51-200 Employees

arraybiopharma.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 30********

Who is ARRAY BIOPHARMA

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted...

Read More

map

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ARRAY BIOPHARMA

Array BioPharma Org Chart and Mapping

Employees

Elaine Gazdeck

Senior Director Qa/Reg Compliance

Tricia Haugeto

Director, Communications & Investor Relations

Adele Golden

Associate Director Biostatistics

Mike Saunders

Senior Director, Drug Safety

Lance Williams

Associate Scientist - Pharmacology

Michelle Vanbeber

Senior Accounts Payable Specialist

Christian George

Clinical Supply Chain Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Array BioPharma

Answer: Array BioPharma's headquarters are located at 3200 Walnut Street, Boulder, Colorado, 80301, United States

Answer: Array BioPharma's phone number is 30********

Answer: Array BioPharma's official website is https://arraybiopharma.com

Answer: Array BioPharma's revenue is $250 Million to $500 Million

Answer: Array BioPharma's SIC: 2834

Answer: Array BioPharma's NAICS: 325412

Answer: Array BioPharma has 51-200 employees

Answer: Array BioPharma is in Pharmaceuticals

Answer: Array BioPharma contact info: Phone number: 30******** Website: https://arraybiopharma.com

Answer: Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access